BCL6.md
... ...
@@ -22,9 +22,9 @@ timeline
22 22
23 23
|Entity|Tier|Description |
24 24
|:------:|:----:|--------------------------------------|
25
-|![BL](images/icons/BL_tier2.png) |2 | aSHM target; Although recurrent, the relevance of mutations in BL is tenuous [@loveGeneticLandscapeMutations2012]|
26
-|![DLBCL](images/icons/DLBCL_tier1.png) |1-EE[@balSuperenhancerHypermutationAlters2022] | aSHM target and high-confidence DLBCL gene [@morinFrequentMutationHistonemodifying2011]|
27
-|![FL](images/icons/FL_tier1.png) |1 | aSHM target and high-confidence FL gene |
25
+|![BL](images/icons/BL_tier2.png) |2 | Although recurrent, the relevance of mutations in BL is tenuous [@loveGeneticLandscapeMutations2012]|
26
+|![DLBCL](images/icons/DLBCL_tier1.png) |1-EE[@balSuperenhancerHypermutationAlters2022] | high-confidence DLBCL gene [@morinFrequentMutationHistonemodifying2011]|
27
+|![FL](images/icons/FL_tier1.png) |1 | high-confidence FL gene |
28 28
29 29
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
30 30